JPMorgan S&P Global 100 5% RC Index update tied to AMJB (AMJB)
Rhea-AI Filing Summary
JPMorgan Chase & Co. provides a January 2026 performance update for the S&P Global 100 PR 5% Daily Risk Control 0.5% Deduction Index (USD) ER. This index gives exposure to the S&P Global 100 Index while targeting 5% annualized volatility and deducting both a 0.50% per year fee and a notional financing cost based on the Effective Federal Funds Rate, calculated daily.
The index is calculated on an excess return basis and was established on September 18, 2023, with levels published under ticker SPGLR5TE. The filing shows hypothetical and actual historical returns and volatility from December 2015 through December 2025 and compares them to two hypothetical 30/70 stock‑bond portfolios. For the index, the 10‑year annualized return is 2.32% with 10‑year annualized volatility of 4.27%, implying a Sharpe Ratio of 0.54 over that period.
The document stresses that backtested and past performance are not indicative of future results and highlights risks, including daily deductions, the possibility that the index may not match its 5% volatility target, may significantly reduce exposure to equities, and may fail to outperform the underlying S&P Global 100 Index or the comparison portfolios. It also notes that CDs linked to the index may not be suitable for all investors.
Positive
- None.
Negative
- None.
FAQ
What is the S&P Global 100 PR 5% Daily Risk Control 0.5% Deduction Index (USD) ER linked to AMJB?
The Index provides exposure to the S&P Global 100 Index while targeting an annualized volatility of 5%. It is calculated on an excess return basis and includes a daily deduction for a 0.50% per year fee plus a notional financing cost referenced to the Effective Federal Funds Rate.
How has the S&P Global 100 5% Daily Risk Control Index performed historically?
The filing presents hypothetical and actual data from December 2015 through December 2025. For that period, the Index shows a 10-year annualized return of 2.32%, 10-year annualized volatility of 4.27%, and a Sharpe Ratio of 0.54. All backtested and past performance is explicitly described as not indicative of future results.
How does the Index compare to the Domestic and Global 30/70 portfolios in the AMJB filing?
The document compares the Index to two hypothetical 30/70 stock‑bond portfolios calculated on an excess return basis. The Domestic 30/70 Portfolio (ER) (30% S&P 500, 70% Bloomberg Barclays U.S. Aggregate) has a 10-year annualized return of 3.26% and volatility of 6.33% with a Sharpe Ratio of 0.52, while the Global 30/70 Portfolio (ER) (30% MSCI ACWI, 70% Bloomberg Barclays Global Aggregate) shows a 10-year annualized return of 1.84%, volatility of 6.18%, and a Sharpe Ratio of 0.30.
What are the main risks highlighted for the S&P Global 100 5% Daily Risk Control Index in this 424B3?
Key risks include: daily deductions for the 0.50% per annum index fee and notional financing cost, potential failure to achieve the 5% volatility target, and the possibility that daily exposure adjustments may prevent the Index from fully reflecting gains or may magnify losses of the underlying index. The Index can also be significantly uninvested, so part of it may earn no return. The filing notes these are not exhaustive and refers readers to broader risk factor sections.
What does the AMJB filing say about backtested versus actual Index performance?
The historical performance measures use backtested data from November 20, 1996 through September 17, 2023 and actual performance from September 18, 2023 through December 31, 2025. The filing clearly states that PAST PERFORMANCE AND BACKTESTED PERFORMANCE ARE NOT INDICATIVE OF FUTURE RESULTS.
How is the Index exposure adjusted over time according to the AMJB supplement?
The Index exposure to the S&P Global 100 Index is dynamically rebalanced daily based on observed volatility of the underlying index. This risk control mechanism can reduce or increase equity exposure and may cause the Index not to fully capture underlying gains or to magnify underlying declines.
What does the AMJB document say about suitability of CDs linked to this Index?
The document states that investment suitability must be determined individually for each investor and that CDs linked to the Index may not be suitable for all investors, underscoring the need to consider the Index’s structure, daily deductions and risk characteristics.

